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Abstract 
In the mouse osteoblastic ell line MC3T3-EI. the ,,ignaling response, of ,,e" eral DNA-binding proteins induced by the treatment of 
neurotrophin-3 were examined using electrophoretic mobility shift assay. Neuro:rophin-3 increased binding activities in nuclear extracts 
of MC3T3-EI cells to TPA-responsive element (TRE). cyclic AMP-responsive lement (CRE) and serum-responsive element (SRE). but 
not binding activity in the nuclear extracts to c-Myc binding DNA element. Competitioh experiments revealed that the binding acti',ity to 
TRE in the nuclear extracts of neurotrophin-3-treated MC3T3-EI cells v, as entirely inhibited by the both unlabeled TRE and CRI~ probes. 
On the other hand. the binding activity to CRE was abolished by the unlabeled CRE probe but not by the same amount of unlabeled TRE 
probe. Moreover, immunodepletion/supershift assay using antibodies directed to Fos. Jun and CREB proteins, showed that the binding 
activities to TRE and CRE in the nuclear extracts v, ere derived in part fi'om these proteins. 
Keywords: Neurotrophin-3: DNA binding activity: Transcriptional f ctor: Electrophoretic mobilit.~--hift assay 
1. Introduction 
Neurotrophic factors, especially neurotrophins such as 
nerve growth factor (NGF). brain-derived neurotrophic 
factor (BDNF) and neurotrophin-3 (NT-3), play an impor- 
tant role in the normal development of the central and 
peripheral nervous systems [I-4]. These factors promote 
the survival and differentiation of various types of neurons 
[5-10]. Recently• the trk family of proto-oncogene prod- 
ucts (TRK), which are members of the family of tyrosine 
kinase receptors, have been identified as the neurotrophin 
receptors [11-13]. NGF and BDNF bind to TRKA and 
Abbreviations: NGF. nerve growth l~actor: BDNF. br:!in-derived neu- 
rotrophic factor: NT-3. neurotrophin-3: TRK. the irk l~mily of proto- 
oneogene products: TRE. TPA-responsive el ment: CRE. cyclic AMP-re- 
sponsive element; SRE. serum-responsive el ment; EMSA. dec- 
trophoretic mobility shift assay. 
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TRKB, respectively [14,15] and NT-3 binds mainly to 
TRKC [16]. 
Neurotrophic factors are also produced by non-neural 
target cells of peripheral neurons [17]. We previously 
demonstrated that osteoblastic ell line MC3T3-EI ex- 
pressed mRNA of neurotropbins and also produced these 
proteins [18]. These findings suggest hat neurotrophins 
produced by osteoblastic ells have developmental nd 
survival efti:cts on bone-associated neurons. On the other 
hand. we recently reported that osteoblastic cells expressed 
receptors for neurotrophins, especially TRKC, and NT-3 
stimulated the proliferation of osteoblastic cells via TRKC 
[19]. This non-neural, novel function of NT-3 suggests the 
involvement of neurotrophic factors in the regulation of 
bone metabolism, it is known that NGF induces the ex- 
pression of immediate-early genes, such as NGFI-A [20,21 ]. 
czfiJs [22-25], c-myc and c-jan [26] in PCI2 cells. These 
immediate-early genes encode transcription factors which 
regulate the induction of late genes, including ornithine 
decarboxylase [27,28], tyrosine hydroxylase [29]. GAP-4"~ 
86 
[30], SCGI0 [31] and VGF [32,33] genes. These late 
gene-related products play important roles in cellular func- 
tions. Although many studies have revealed the molecular 
mechanism of NGF action, little is known about the intra- 
cellular response to NT-3. In the present study, we exam- 
ined NT-3-dependent changes in DNA-binding activities 
which bound to several DNA-binding motit~. 12-O-tetra- 
decanoylphorbol-13-acetate (TPA)-responsive lement 
(TRE), cyclic AMP-responsive lement (CRE), serum-re- 
sponsive element (SRE) and c-MYC-binding element in 
the nuclear extracts of MC3T3-EI cells using elec- 
trophoretic mobility shift assay (EMSA). 
2. Materials and methods 
2.1. Cell culture and reagents 
MC3T3-EI osteoblastic ells derived from C57BL/6 
newborn mouse calvaria [34.35] were kindly provided by 
Dr. Hiroaki Kodama, Ohu University Dental School. The 
cells were grown in a-minimum essential medium (ICN 
Biomedicals Inc., Costa Mesa. CA. USA) supplemented 
with 2% fetal bovine serum (Bioserum. Victoria. Aus- 
tralia) under 5% CO, in air at 37°C. The cells were 
inoculated at a density of 5 X 104 cells/ml. Three days 
after the inoculation of cells, 20 ng/ml of NT-3 (Pepro 
Tech Inc., Rocky Hill. NJ, USA) was added to each 
culture. The cells were harvested at the appropriate times 
for preparation of nuclear extracts. 
2.2. Preparatior, of  nuclear extracts 
Nuclear extracts were prepared from the cultured 
MC3T3-EI cells at the appropriate times after NT-3 stimu- 
lation according to the method of Schreiber et al. [36] with 
minor modifications. In brief, the cultured ceils collected 
in I ml of Tris-buffered saline (25 mM Tris-HCI (pH 7.4), 
130 mM NaCI and 5 mM KCI) were centrifuged at 7000 × 
g for 30 s. The pellet was suspended in 400 p.I of buffer A 
(10 mM Hepes (pH 7.9), l0 mM KCI, 0,1 mM EDTA, 0.1 
mM EGTA, I mM dithiothreitol and 1 mM phenylmethyl- 
sulfonyl fluoride). The suspension was placed on ice for 15 
rain. Then 30 /~l of 10% Nonident P-40 was added, and 
vigorously mixed for l0 s. The nuclear fraction was pre.. 
cipitated by centrifugation at 15000×g for 5 rain and 
suspended in 50 ~l of ice-cold buffer B (20 mM Hepes 
(pH 7.9), 400 mM NaCI, I mM EDTA, I mM EGTA, I 
mM dithiothreitol and 1 mM phenylmethylsulfonyl fluo- 
ride). The mixture was placed on ice for 15 rain with 
frequent agitation. Then the supernatants of the nuclear 
extracts were prepared by centrifugation at 15000 × g for 
5 rain and stored in aliquots at -80°(2. The protein 
concentration was determined using a Bio-Rad protein 
assay kit with bovine serum albumin as a standard. 
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2.3. Electrophoretic mobili O" shift assay (EMSA) 
Double-stranded oligonucleotides indicated in Fig. 1 
were labeled with [o~-3-'P]dCTP (Amersham International, 
Amersham, UK) using DNA polymerase 1(Klenow frag- 
ment) and purified by Sephadex G-50 column chromatog- 
raphy. 
The DNA-protein binding reaction was performed for 
15 rain at 20°C in a reaction mixture (20/zl) containing 20 
mM Hepes-NaOH (pH 7.9). 2 mM Tris-HCI, I mM dithio- 
threitol, 0.4 mM EDTA. 0.2 mM EGTA, 80 mM NaCI, 2 
#g of poly(dl-dC), 10% glycerol, 0.2 mM phenylmethyl- 
sulfonyl fluoride. 200 pg of 32P_labeled ouble-stranded 
oligonucleotide probes, and nuclear extract (2 #g). In the 
case of competition assays, the reaction was performed in 
the presence of excess volume of non-radiolabeled com- 
petitor DNAs. 
For immunodepletion/supershift assay, 4 /zl of anti-c- 
Fos antibody (c-fos (K-25), Santa Cruz Biotechnology, 
Santa Cruz, CA), anti-c-Jun antibody (c-jun/AP-I (D), 
Santa Cruz Biotechno[ogy, Inc.) or anti-CREB antibody 
(CREB-I (C-21). Santa Cruz Biotechnology) were incu- 
bated with nuclear extract for 1 h at 4°C before EMSA. 
The DNA-protein complexes were resolved on 4% poly- 
acrylamide gel (30:1 cross-linking ratio) containing 6.7 
mM Tris-HCI (pH 7.6), 3.3 mM sodium acetate, 2,5% 
glycerol, I mM EDTA and 0.06% ammonium persulfate. 
Electrophoresis was carried out at I I V/cm for 2.5 h at 
4°C. After gel electrophoresis, the gel was dried and 
exposed to X-ray film (Kodak X-OMAT, Eastman Kodak, 
Rochester, NY) with intensifying screens for 1 day at 
-80°C. The reactive density of detected bands on the 
autoradiograms was measured and analyzed with an image 
scanner (Epson GT-6500, Seiko-Epson, Tokyo) and com- 
puterized image analysis software (Image 1.44, NIH). 
2.4. Northern blot analysis 
Subeonfluent MC3T3-E1 cells were cultured with ar 
without NT-3 (20 ng/ml) and harvested at the appropriate 
times after the stimulation with NT-3. Total RNA was 
TRE : 5'-GATTCGTGACTCAGCACAGG-3' 
3'-CTAAGcACTGAGTCGTGTCC-S' 
CRE : 5'-GATTCGTGACGTCAGCAGAG-3' 
3'-CTAAGcACGTAAGTCGTGTC-5" 
SRE : 5'-TATGGATGTGCATATTAGGACATCTACA-3' 
3'-ATACCTACAGGTATAATCGTGTAGATGT-5' 
c-Myc : 5'-AAGGAGACCACGTGGTCAGGCTA-3' 
3'°TT C GTCTGGI"(~ C.~CcAGTCCG AT-5' 
Fig. 1. Oligonucleotide s quences u ed as probes or competitors for 
EMSA, Consensus sequences of TRE [42], CRE. SRE and c-MYC [43] 
are indicated inbold letters. 
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isolated from the cells by the method of Wi lk inson [37] 
and denatured with 6.7ck formaldehyde-50c~ lormamide 
solution. The denatured RNA (5 ,ug /ml )  was elec- 
trophoresed on I% agarose / formaldehyde g ls and then 
the RNA was transblotted irectly onto a nylon membrane 
(Hybond-N.  Amersham).  Murine osteosarcoma virus 
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Fig. 2. Effects of NT-3 on TRE-. CRE-. SRE- and c-MYC-binding activities in nuclear extracts of MC3T3-EI cells. Nuclear extracts were prepared from 
MC3T3-EI cells at the indicated times after incubation with 20 ng/ml of NT-3. Two mic,ogram~ of proteins from nuclear extracts were incubated with 
~" P-labeled double-strand oligonucleotide probes and subjected to electrophoresi~. Gels v.ere exposed to X-ray film (top} and analyzed with an image 
scanner (bottom). Arrowheads point to the shifted bands. (A) TRE. tB) CRE. (C) SRE and ~D) c-MYC. Changes in DNA-binding activity are also plotted. 
(11) NT-3. (D) PBS-treated. 
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(MgV)-derived v-fi~s DNA probe (I kb Pstl-Prull  frag- 
ments) (Takara Shuzo. Otsu. Japan) was radiolabeled with 
[o~-3-'P]dCTP (Amersham Int. pie) using a random prime 
labeling kit (Amersham). Blots were pre-hybridized for 3 h 
at 42°C in hybridization buffer (5 x SSC, 5 × Denhardt's 
solution, 50% formamide. 0.5ok SDS and 20 Izg/ml dena- 
tured salmon sperm DNA). Hybridization was performed 
for 18 h at 42°C in the same buffer containing about 105 
Bq/ml  3"~ P-labelled DNA probes. After the hybridization, 
membranes were washed twice with 1 × SSC containing 
0.1% SDS for 15 min at room temperature, then washed 
for 30 min at 50°C and exposed to X-ray film (Hyperfilm 
MP, Amersham Int. plc) for 5 days at - 80°C. The relative 
density of the exposed bands on the film was measured 
with an image scanner (Epson GT-6500) and image analy- 
sis software (Image 1.44. NIH). 
3. Results 
3.1. hwrease t~f DNA-binding acticities tbt" sereral tran- 
scril, tion factors in nuclear extracts of  MC3T3-EI cells by 
NT-3 
Binding activities of nuclear proteins to probes of TRE, 
CRE, SRE and c-MYC were analyzed by EMSA. MC3T3- 
El cells were incubated with NT-3 (20 ng /ml )  and har- 
vested at 0. 1, 2, 6 and 12 h after the stimulation to prepare 
nuclear extracts for EMSA. As shown in Fig. 2, binding 
activities to TRE, CRE and SRE in the nuclear extracts 
increased 2 h after the addition of NT-3, and this increased 
level persisted for more than 12 h after the stimulation. 
The increased levels of TRE- and CRE-binding activities 
in the nuclear extracts of NT-3- treated MC3T3-EI cells 
were 1.8- to 2.3-fold and 1.2- to 1.45-fold. respectively, 
compared with the activities of non-treated cells (Fig. 
2A,B). Three bands were detected for nuclear proteins 
bound to SRE. Especially, the induction of the upper band 
was remarkable (Fig. 2C); NT-3-induced leve~ of radiola- 
bel of the upper band was 3.0-3.5 times that of non-treated 
control cells. On the other hand, the level of the lower 
band was not increased by treatment with NT-3. No signif- 
icant difference was observed in the binding activities to 
probes for c-MYC (Fig. 2D). 
3.2. Competition assays t~f the "[RE- and CRE-binding 
acticities of nuclear proteins 
Becaa,~e of the similarity of the nucleotide sequences of 
TRE and CRE, we campared the binding abilities of TRE 
and CRE by using competition assays between labeled and 
unlabeled probes to analyze the binding specificity of 
TRE- or CRE-binding activity. We used the nuclear ex- 
tracts collected 6 h after NT-3 stimulation and changed the 
molar ratios of competitor unlabeled probes to labeled 
probes (3-, 10-, 30-, 100- and 200-fold). The addition of 
unlabeled CRE probes dose-dependently inhibited TRE-bi- 
nding activity in the nuclear protein to the same extent as 
when unlabeled TRE probes were used as competitors 
(Fig. 3A). TRE-binding activity was entirely inhibited by 
both TRE and CRE unlabeled probes at a 200-fold excess 
of unlabeled versus labeled probes. Conversely, unlabeled 
TRE probes inhibited CRE-binding activity (Fig. 3B). 
Although the binding activities to labeled CRE probe were 
abolished by the addition of 200-fold of excess unlabeled 
CRE probe, the addition of 200-fold excess unlabeled TRE 
A.  P robe  :~ 'P - labe led  TRE 
unlabeled TIRE unlabeled CRE 
@@@- il!#'~ 
B. P robe  :~P- labe led  CRE 
unlabeled TIlE unlabeled CRE 
1 23456 123 456 1 23  4 56  1 23  456  
Fig. 3. Competition f TRE- and CRE- binding activities. Nuclear extracts were prepared from MC3T3-EI cells 6 h after treatment of 20 ng/ml of NT-3. 
A: TRE probe, B: CRE probe. Unlabeled TRE or CRE oligonucleotide was added at the following molar atios: (ll 32 P-labeled probe only (control). (2) 
3-fold exess of unlabeled probe, (3) 10-fold excess of unlabeled probe, (4) 30-fold excess of unlabeled probe, (5) 100-fold excess of unlabeled probe. (6) 
200-fold excess of unlabeled probe. 
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Fig. 4. Results of competitor experiments. Each band shown in Fig 3 v.as measured and anal)ted wuth an image ~canner (Epson GT-6500) and 
computerized image analysis ol, ware (Image 1.44 NIH). The extent of Lompetition x~a, calculated as a percentage of the control. (El I unlabeled "IRE 
probe. (• )  unlabeled CRE probe. 
probe only reduced the CRE-binding activities to approxi- 
mately 70% of the total binding activities (Fig. 4). 
3.3. Immunodepletion / supers'hift ~" the band Jormed bv 
TRE- and CRE-binding acticit3" 
Tn quantitate the amount of c-Fos, c-Jun and CREB 
proteins contained in the DNA-protein complexes formed 
with TRE and CRE probes, we performed an immunode- 
pletion/supershift assay using antisera raised against c-Fos, 
c-Jun and CREB proteins. Anti-c-Fos antibody was reac- 
tive with Fos-family proteins as well as the c-Fos protein. 
Likewise, anti-c-Jun antibody was cross-reactive with 
Jun-family proteins. 
When the nuclear extracts of MC3T3-EI cells harvested 
6 h after the NT-3 stimulation were preincubated with 
anti-c-Jun antibody and then incubated with radiolabeled 
probes, a new band of higher molecular weight appeared, 
indicating the presence of a DNA-protein-antibody com- 
plex (Fig. 5). About 40% of total binding activity to TRE- 
or CRE-probe ~as shifted to a higher molecular weight. 
On the other hand. normal rabbit antiserum had no signifi- 
cant effect on the banding pattern (Fig. 5). Pretreatment of
anti-CREB antibody reduced the signals of DNA-binding 
proteins bound to TRE and CRE sequences to 56% and 
48%. respectively (Fig. 5). On the other hand. the addition 
of anti-c-Fos antibody reduced the TRE-binding activity to 
62% of the total binding activity. CRE-binding activity 
was slightly reduced by pretreatment with anti-c-Fos anti- 
body. 
A. TRE B. CRE 
AnUbody : NR Fos NR Jun NR CREB Antibody : NR Fos NR,Jun NR CREB 
- .mmi  , - , .  m,uan 
1 2 34  5 6 1 2 34  5 6 
Fig. 5. lmmunodepletion/supershift assay to "IRE- and CRE-binding activitnes. Nuclear extract~ were prepared from MC3T3-EI cells 6 h after treatment 
of 20 ng/ml of NT-3. A: TRE probe. B: CRE probe. (1,3.5) nuclear extracts were preincubated '.,.ah normal rabbit antiserum. (2) preincubated with 
anti-c-Fos antibody, (4) preincubated with anti-c-Jun antibod3,, and (6l preincubated with anti-CREB antibody. Arrowheads point o the shifted bands. 
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Fig. b. The expression level of c:/~,~ mRNA in NT-3-stirnu[ated MC3T3- 
El cell~,. MC3T3-EI cells vcere harvested at the indicated times al~er the 
addition of 20 ng/ml of NT-3 |br preparation f RNA. Total RNA (5 
/zg/lane) ~as subjected toNorthern blot analysis using ~" P-labeled c:/bs 
eDNA as a probe. The membrane was exposed to X-ray film after the 
hybridization (A). The intensity ofthe bands corre~,ponding to the mRNA 
size of c-fi~s was analyzed by an image scanner IB). 111"1 NT-3, (13) 
PBS-treated. 
3.4. bMttction b ide  noro synthesis ~g' c:/'os mRNA in 
MC3T3-EI  cells 
To clarify whether the enhancement of DNA-binding 
activity shown in Fig. 2 was caused by enhancement of
DNA-binding activity of pre-existed proteins or induction 
of de novo synthesis of DNA-binding proteins, we per- 
formed Northern blot analysis of c:fos mRNA because 
supershift analysis howed that c-Fos was contained in the 
DNA-binding activities to TRE and CRE. As shown in 
Fig. 6. the level of c-fos mRNA was rapidly increased in 
MC3T3-EI cells by the addition of NT-3, indicating that 
NT-3-dependent enhancement of the DNA-binding activity 
was caused mainly by the induction of de novo synthesis 
of the DNA-binding proteins. 
4. Discussion 
In this study, we found that NT-3 increased DNA 
binding activities to TRE, CRE and SRE probes in the 
nuclear extracts of MC3T3-E1 cells. We also detected 
c-Fos, c-Jun and CREB proteins in the DNA binding 
activities to TRE and CRE. This is the first report on 
changes in DNA binding activities of these mmscription 
factors in response to NT-3. 
Among many immediate-early genes, overexpression f 
c-fi~s, c-tim and c-myc genes led to cellular transformation. 
and it is considered that these genes promote cellular 
proliferation. These immediate-early genes encode tran- 
scription factors which are thought to play an important 
role in regulating the transcription of the target genes 
which contribute to generating long-lasting or flexible 
alterations of particular cellular esponses such as survival, 
proliferation a,nd differentiation. 
In the case of osteoblastic cells, we have already re- 
po[icd that NT-3 stimulated the proliferation of MC3T3-EI 
cells [19] and in the present study, we showed that there 
was an increase in TRE. CRE and SRE binding activities 
in the nuclear extracts of the cells at 2 h and still an 
appreciable increase at 12 h following treatment with 20 
ng /ml  of NT-3 (Fig. 2A.B.C). These changes were also 
observed in the cells treated with I ng /ml  of NT-3. 
although the levels were lower than that observed in the 
cells treated with 20 ng /ml  of NT-3 (data not shown). As 
a result, the concentration of NT-3 required to stimulate 
the proliferation of MC3T3-EI cells was almost the same 
as those needed to increase the DNA binding activities to 
TRE. CRE and SRE probes. These data suggest that NT-3 
treatment could lead to an increase in DNA-binding activi- 
ties of particular transcription factors, for example c-Fos. 
c-Jun and CREB. and of other transcription factors which 
are associated with the TRE, CRE and/or  SRE DNA 
binding motifs, and these factors may regulate the tran- 
scription of the target genes with these motifs in their 
upstream regions which, in turn, promote the proliferation 
of MC3T3-EI cells. On the contrary, no significant eleva- 
tion of c-MYC binding activity was noted in NT-3-treated 
MC3T3-EI cells (Fig. 2D). In the osteoblastic ell llne 
MC3T3-EI. c-Myc may not contribute to the NT-3-in- 
duced proliferation. 
In the competition assays of nuclear extracts obtained 
from the MC3T3-EI cells 6 h after the NT-3 treatment 
using labeled and unlabeled DNA probes, the addition of 
not only unlabeled TRE probe but also unlabeled CRE 
probe inhibited the TRE-binding activity of nuclear ex- 
tracts dose-dependently (Fig. 3A). Conversely, not only 
unlabeled CRE probe but also unlabeled TRE probe inhib- 
ited the CRE-binding activity of nuclear extracts (Fig. 3B). 
These results suggest hat TRE- and CRE-binding activi- 
ties were induced in part via activation or synthesis of 
common DNA-binding factors that recognized both TRE 
and CRE motifs. Recently, it has been reported that, in 
cultured cerebellar granule cells, activation of NMDA or 
kainate receptors induced TRE- and CRE-binding activi- 
ties mediated by common DNA-binding complexes [38]. 
However, the inhibition of CRE binding activity by TRE 
probe was only 30% of the total binding activities even 
when the 200-fold excess unlabeled TRE probe was used 
(Fig. 4B). These data suggest hat there are other DNA 
binding factors induced by NT-3 which selectively recog- 
nize the CRE probe. It is known that AP-I has a high 
affinity for both the TRE and CRE sequences. On the other 
hand. CREB/ATF  protein has higher DNA-binding affin- 
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ity for CRE than for TRE. So. in MC3T3-EI cells. 
CREB/ATF  protein might recognize CRE selectively and 
bind weakly to TRE because of the high homology of 
nucleotide sequences between CRE and TRE. 
Furthermore. we examined immunodepletion/super- 
shift assays. The protein composition of the shifted bands 
were investigated using antibody against components of 
the AP-I and CREB/ATF  complexes. Anti-c-Fos and 
anti-c-Jan antibodies affected not only the signals of TRE- 
binding activity but also the signals of CRE-binding activ- 
ity (Fig. 5). These antibodies might recognize the AP-I 
complex that cross-reacts with the CRE sequence. AP-I 
transcription factor consists of either Jan homodimers or 
Fos / Jun  heterodimers, which bind the TRE sequence and 
homologous CRE sequence. Furthermore. it has been well 
documented that certain CREB/ATF  proteins can form 
leucine zipper dimers with members of the AP-I transcrip- 
tion factor family [39]. The CREB/ATF  family binds to 
the CRE sequence selectively. Thus, these antibodies might 
also recognize the AP-I component which were included 
in CRE-binding proteins. 
Anti-CREB-antibody also reduced the signals of DNA- 
binding protein,', bound to both TRE and CRE (Fig. 5). 
suggesting that CREB/ATF  transcription factors cross- 
bind to the TRE sequence or bind to TRE via the AP..I 
complex. Another possibility is that the anti-CREB-anti- 
body recognized the c-Jun protein included in AP-I be- 
cause the anti-CREB-antibody used in this experiment 
reacts with the DNA-binding domain of CREB and it is 
known that CREB proteins are about 50% similar to Jun 
proteins in this basic DNA-binding domain [40]. 
In addition, high molecular weight-shifted extra bands 
which contain DNA-protein-antibody complexes were ob- 
served only in the case of anti-c-Jun antibody (Fig. 5). It is 
assumed that anti-c-Fos and anti-CREB antibodies recog- 
nize DNA binding sites on the c-Fos and CREB molecules. 
respectively, and then inhibit the binding of protein-anti- 
body complexes to DNA probes. 
NoTthern blot analysis revealed that NT-3 induced the 
expre'ision of c- f i~s mRNA in MC3T3-EI cells (Fig. 6). It 
has been reported that serum growth factors induce phos- 
phorylation of  transcription factor p62 Tcv by MAP kinase 
and stimulates ternary complex tormation at c - fos  pro- 
moter which leads induction of c-fos mRNA expression 
[41]. We have already shown that NT-3 stimulates the 
proliferation of MC3T3-EI cells [19], so the induction of 
c - fos  mRNA expression by NT-3 may be caused in a 
similar manner. The induction of c - fos  mRNA expression 
in the NT-3-stimulated MC3T3-EI cells strongly suggests 
that the enhancement of DNA-binding activity in the cells 
resulted from stimulation of de novo synthesis of c-Fos 
protein. 
in the previous study, we found that NT-3 and its 
receptor TRKC were co-expressed in the proliferating 
phase of osteoblastic MC3T3-EI cells and that NT-3 stim- 
ulates the proliferation of MC3T3-EI cells via TRKC. In 
this study, we showed that exogenous NT-3 induced 
DNA-binding activities of particular transcription factors 
in the cells. These transcription factors may modulate 
transcription of certain genes, which play an important role 
in the proliferation of os;.eoblastic cells. Future investiga- 
tions searching for the target genes of these transcription 
factors in osteoblastic cells are now under way. 
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